Medicines labeled for the same conditions

Alternatives to certolizumab

9 other medicines are given the same way (subcutaneous) and in the same FDA class as certolizumab or labeled mainly for the same use (rheumatoid arthritis); 3 are in its class, tumor necrosis factor blockers: adalimumab, etanercept and golimumab; the others include 2 interleukin-6 receptor antagonists, 1 folate analog metabolic inhibitor and 1 selective t cell costimulation modulator (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $1,587.82 per mL (Adalimumab-adaz(cf) pen 40 mg/0.4 mL) (what pharmacies paid in the NADAC survey; strengths differ).

Which medicines are labeled for the same conditions as certolizumab?

Rheumatoid arthritis lists all 46 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA class	Shared indication	Generic labelers (subcutaneous)	Pharmacy cost	Boxed warning	Shortage
Certolizumabtumor necrosis factor blocker	this medicine	none listed	$6,094.02 per syringe 2x200 mg/mL syringe kit	Yes	No current entry
Adalimumabtumor necrosis factor blocker · same class	Rheumatoid arthritis, Crohn's disease and ulcerative colitis, Psoriasis	none listed	$1,587.82 per mL 40 mg/0.4 mL	Yes	No current entry
Etanercepttumor necrosis factor blocker · same class	Rheumatoid arthritis, Psoriasis	none listed	$2,084.14 per mL 25 mg/0.5 mL syringe	Yes	No current entry
Golimumabtumor necrosis factor blocker · same class	Rheumatoid arthritis, Crohn's disease and ulcerative colitis	none listed	$12,890.32 per mL 50 mg/0.5 mL pen injec	Yes	No current entry
Methotrexatefolate analog metabolic inhibitor	Rheumatoid arthritis, Psoriasis	none listed	$289.37 per mL 25 mg/0.5 mL autoinj	Yes	In shortage
Tocilizumabinterleukin-6 receptor antagonist	Rheumatoid arthritis	none listed	$821.00 per mL 162 mg/0.9 mL autoinjct	Yes	No current entry
Adalimumab-ryvk	Rheumatoid arthritis, Crohn's disease and ulcerative colitis, Psoriasis	none listed	$499.12 per unit 40 mg/0.4 mL autoinjector	Yes	A presentation being discontinued
Sarilumabinterleukin-6 receptor antagonist	Rheumatoid arthritis	none listed	$2,075.30 per mL 200 mg/1.14 mL pen injection	Yes	No current entry
Abataceptselective t cell costimulation modulator	Rheumatoid arthritis	none listed	$1,469.23 per mL 125 mg/mL syringe	No	No current entry
Adalimumab-aacf	Rheumatoid arthritis, Crohn's disease and ulcerative colitis, Psoriasis	none listed	n/a	Yes	No current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Methotrexate$289.37
Adalimumab-ryvk$499.12
Tocilizumab$821.00
Abatacept$1,469.23
Adalimumab$1,587.82
Sarilumab$2,075.30
Etanercept$2,084.14
Golimumab$12,890.32

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Certolizumab: the full record: label, generics, price, shortages, recalls
Certolizumab vs golimumab: two records side by side
Abatacept vs certolizumab: two records side by side